COMMUNIQUÉS West-GlobeNewswire

Nine Levers Employers Can Use to Improve Brain Health and Workplace Performance

27/01/2025 - 15:00

New unified model developed by UsAgainstAlzheimer's, the Davos Alzheimer's Collaborative and the McKinsey Health Institute provides roadmap for employers to promote employee brain health for better business outcomes [...]

Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education

27/01/2025 - 15:00

Latest donation brings total contribution to more than $170 million SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of [...]

Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day

27/01/2025 - 15:00

- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT ® - - Ad-hoc analyses of pancreatic cancer population subgroups [...]

FDA Authorizes Myocene Device for Muscle Fatigue Monitoring and Informed Training Decisions

27/01/2025 - 15:00

LIÈGE, Belgium, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Myocene, the Belgian sportstech company specializing in innovative muscle fatigue assessment for top-level athletes announced today that the US Food and Drug [...]

KFSHRC Heart Centre: A Leader in Advanced Cardiac Treatments

27/01/2025 - 14:30

Revolutionizing care from minimally invasive surgery to comprehensive outpatient services RIYADH, Saudi Arabia, Jan. 27, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has [...]

Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT

27/01/2025 - 14:30

Study is the first randomized, controlled trial examining a vaccine’s effectiveness in controlling CMV in recipients of HSCT from vaccinated donors Encouraging pilot study results demonstrated the benefit of vaccinating [...]

Novo Nordisk A/S - share repurchase programme

27/01/2025 - 14:05

Bagsværd, Denmark, 27 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]

Umoja Biopharma Announces Appointment of Dr. Luke Walker as Chief Medical Officer

27/01/2025 - 14:05

SEATTLE, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today announced the [...]

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements

27/01/2025 - 14:01

BERKELEY, Calif. and MAINZ, Germany, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]

Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium

27/01/2025 - 14:00

BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]

Life Biosciences Appoints Dr. Michael Ringel as Chief Operating Officer

27/01/2025 - 14:00

BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the [...]

Aspargo Labs Appoints Harold D. Tamayo as Chief Financial Officer

27/01/2025 - 14:00

Experienced financial leader joins as the company prepares for its public market entry NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc., (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech [...]

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

27/01/2025 - 14:00

ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received European CE Mark [...]

iCAD Pre-Announces Estimated Q4 2024 Revenue

27/01/2025 - 14:00

iCAD to Participate in the BTIG at Snowbird: 12 th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, N.H., Jan. 27, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the [...]

Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

27/01/2025 - 14:00

JERUSALEM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that it will [...]

Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer

27/01/2025 - 14:00

Acuitive Technologies announces the appointment of Dr. Wayne Berberian as Chief Medical Officer. In this role, Dr. Berberian will drive the company’s strategy behind new product development of first-in-class [...]

Dentzz Dental Reports Serving Over 100,000 Patients Worldwide, Highlighting Dental Tourism Trends

25/01/2025 - 03:43

Photo credit: Dentzz Dental MUMBAI, India, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Dentzz Dental, a leading provider of advanced dental care, has announced that it has served over 100,000 patients worldwide since its founding [...]

Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

24/01/2025 - 23:34

This expansion is in addition to the previously announced Microsoft for Startups program. PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target identification. Tevogen [...]

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24/01/2025 - 22:05

MALVERN, Pa., Jan. 24, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]